Home / Private raises / Klothea Bio, Inc.
Klothea Bio, Inc.
Other Health Care · Miami, Florida · $8.6M sold across 1 offering
Form D filings (2)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | D/A (update) | $8.6M | $10.4M | 26 | 506(b) | Debt, Options/warrants, Security to be acquired | Oct 11 | SEC ↗ |
| 2026-09-08 | D/A (update) | $6.9M | $10.4M | 22 | 506(b) | Debt, Options/warrants, Security to be acquired | Oct 11 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Sold through (placement agents)
| Broker-dealer | Solicited in |
|---|---|
| Finalis Securities, LLC | All States |
Sales commissions $101K in the latest filing.
Issuer
| Industry | Other Health Care |
| Located | Miami, Florida |
| Entity | Corporation |
| Incorporated | Delaware, 2024 |
| SEC CIK | 2042705 |
People named in the latest filing
| Name | Role |
|---|---|
| Jeffrey B. Madden | Executive Officer, Director |
| Agustin Fernandez Santana III | Executive Officer, Director |
| Olivier Jarry | Executive Officer |
| Walter Schmidt | Director |
| Petr Sramek | Director |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
